Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Clinical Laboratory|November 3, 2006
Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorptionJussi M Halleen, Sari L Tiitinen, Hannele Ylipahkala, et al.Clinical Laboratory|September 5, 2009
Specificity and clinical performance of two commercial TRACP 5b immunoassaysHannele Ylipahkala, Katja M Fagerlund, Anthony J Janckila, et al.Journal of Bone and Mineral Metabolism|November 20, 2008
Improved methods for testing antiresorptive compounds in human osteoclast culturesJukka P Rissanen, Hannele Ylipahkala, Katja M Fagerlund, et al.Scientific Reports|March 4, 2016
In vitro model of bone to facilitate measurement of adhesion forces and super-resolution imaging of osteoclastsTakahiro Deguchi, Maria H Alanne, Elnaz Fazeli, et al.Archives of Biochemistry and Biophysics|April 20, 2006
Effects of proteolysis and reduction on phosphatase and ROS-generating activity of human tartrate-resistant acid phosphataseKatja M Fagerlund, Hannele Ylipahkala, Sari L Tiitinen, et al.Journal of the National Cancer Institute|May 18, 2013
Survival benefit with radium-223 dichloride in a mouse model of breast cancer bone metastasisMari I Suominen, Jukka P Rissanen, Rami Käkönen, et al.Clinical Laboratory|December 23, 2008
Clinical performance of six different serum tartrate-resistant acid phosphatase assays for monitoring alendronate treatmentKatja M Fagerlund, Anthony J Janckila, Hannele Ylipahkala, et al.International Journal of Molecular Sciences|June 2, 2021
Additive Benefits of Radium-223 Dichloride and Bortezomib Combination in a Systemic Multiple Myeloma Mouse ModelMari I Suominen, Jenni Mäki-Jouppila, Anna Huhtinen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 2, 2017
Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse ModelsMari I Suominen, Katja M Fagerlund, Jukka P Rissanen, et al.Pageof 1